OPKO Health (OPK) News Today $1.58 +0.02 (+1.28%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Phillip Md Et Al Frost Acquires 100,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 100,000 shares of the stock in a transaction on Friday, November 22nd. The shares were bought at an average price of $1.59 per share, for a total transaction of $159,000.00. Following the purchase, the chief executive officer now owns 211,712,405 shares in the company, valued at approximately $336,622,723.95. This trade represents a 0.05 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website.November 22 at 7:18 PM | marketbeat.comOPKO Health to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNovember 20 at 9:30 AM | markets.businessinsider.comNextPlat (NASDAQ: NXPL) Expands OPKO Product Promotion at Asia’s Largest Health ExpoNovember 19, 2024 | theglobeandmail.comNextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition ExpoNovember 18, 2024 | prnewswire.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Acquires 100,000 SharesNovember 15, 2024 | insidertrades.comPhillip Frost Buys Handful Of Shares In OPKO HealthNovember 11, 2024 | finance.yahoo.comBarrington Research Estimates OPKO Health FY2028 EarningsOPKO Health, Inc. (NASDAQ:OPK - Free Report) - Equities research analysts at Barrington Research increased their FY2028 earnings estimates for shares of OPKO Health in a report released on Friday, November 8th. Barrington Research analyst M. Petusky now forecasts that the biotechnology company wiNovember 11, 2024 | marketbeat.comOPKO Health Shows Strategic Progress in Q3 2024November 9, 2024 | markets.businessinsider.comOPKO Health Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagNovember 9, 2024 | finance.yahoo.comInsider Buying: OPKO Health, Inc. (NASDAQ:OPK) CEO Buys 280,183 Shares of StockNovember 9, 2024 | insidertrades.comOPKO Health: Strategic Maneuvers and Future Profitability Drive Buy RatingNovember 9, 2024 | markets.businessinsider.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 280,183 SharesOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost purchased 280,183 shares of the stock in a transaction dated Friday, November 8th. The shares were acquired at an average cost of $1.50 per share, for a total transaction of $420,274.50. Following the completion of the acquisition, the chief executive officer now directly owns 211,512,405 shares of the company's stock, valued at approximately $317,268,607.50. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this link.November 8, 2024 | marketbeat.comOPKO Health's (OPK) Outperform Rating Reiterated at Barrington ResearchBarrington Research restated an "outperform" rating and set a $2.25 price target on shares of OPKO Health in a report on Friday.November 8, 2024 | marketbeat.comOPKO Health Inc (OPK) Q3 2024 Earnings Call Highlights: A Turnaround in Profitability Amidst ...November 8, 2024 | finance.yahoo.comOPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call TranscriptNovember 7, 2024 | seekingalpha.comOPKO Health Reports Third Quarter 2024 Business Highlights and Financial ResultsNovember 7, 2024 | finance.yahoo.comOPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Assenagon Asset Management S.A.Assenagon Asset Management S.A. boosted its stake in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 142.5% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 1,490,992 shares of the biotechnology company's stock after acquiring an additional 876,272 sharNovember 1, 2024 | marketbeat.comOPKO Health (OPK) Set to Announce Earnings on ThursdayOPKO Health (NASDAQ:OPK) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=641656)October 31, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Shares Up 4.7% - What's Next?OPKO Health (NASDAQ:OPK) Stock Price Up 4.7% - Should You Buy?October 29, 2024 | marketbeat.comWith 50% ownership, OPKO Health, Inc. (NASDAQ:OPK) insiders have a lot riding on the company's futureOctober 18, 2024 | finance.yahoo.comRenaissance Technologies LLC Cuts Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK)Renaissance Technologies LLC lowered its holdings in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 79.3% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 284,743 shares of the biotechnology company's stock after selling 1,0October 12, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Stock Price Up 4.1% - Time to Buy?OPKO Health (NASDAQ:OPK) Shares Up 4.1% - Here's What HappenedOctober 9, 2024 | marketbeat.comSquarepoint Ops LLC Acquires Shares of 473,216 OPKO Health, Inc. (NASDAQ:OPK)Squarepoint Ops LLC bought a new position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 473,216 shares of the biotechnology company's stock, valued at apprOctober 9, 2024 | marketbeat.comModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza ProgramOctober 7, 2024 | globenewswire.comOPKO Health (NASDAQ:OPK) Stock, Insider Trading ActivityOctober 5, 2024 | benzinga.comOPKO Health (NASDAQ:OPK) Trading Up 5%OPKO Health (NASDAQ:OPK) Trading Up 5%October 2, 2024 | marketbeat.comGlobal Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030 | DelveInsightSeptember 26, 2024 | finance.yahoo.comBuy Rating Justified by Opko Health’s Promising OXM Candidate and Strategic Asset SaleSeptember 26, 2024 | markets.businessinsider.comEntera Bio, OPKO Health Announce Positive Results For Oxyntomodulin Animal Models Against ObesitySeptember 25, 2024 | markets.businessinsider.comOPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical DevelopmentSeptember 23, 2024 | markets.businessinsider.comOPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Rubric Capital Management LPRubric Capital Management LP boosted its position in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 800.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 44,422,304 shares of the biotechnology company's stock aSeptember 21, 2024 | marketbeat.comOpko Health’s Strategic Moves and Financial Prospects Bolster Buy RatingSeptember 21, 2024 | markets.businessinsider.comOPKO Health (NASDAQ:OPK) Earns "Outperform" Rating from Barrington ResearchBarrington Research reissued an "outperform" rating and set a $2.25 price objective on shares of OPKO Health in a research note on Friday.September 20, 2024 | marketbeat.comGeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA AnalyticsSeptember 20, 2024 | msn.comOpko Health (OPK) Receives a Buy from Piper SandlerSeptember 18, 2024 | markets.businessinsider.comOpko Health’s Strategic Moves and Pipeline Progress Prompt Buy RatingSeptember 18, 2024 | markets.businessinsider.comOPKO Health (NASDAQ:OPK) Stock Price Down 2.4%OPKO Health (NASDAQ:OPK) Stock Price Down 2.4%September 18, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Shares Gap Down to $1.64OPKO Health (NASDAQ:OPK) Shares Gap Down to $1.64September 17, 2024 | marketbeat.comPiper Sandler Reiterates Overweight Rating for OPKO Health (NASDAQ:OPK)Piper Sandler reaffirmed an "overweight" rating and set a $3.00 target price on shares of OPKO Health in a report on Tuesday.September 17, 2024 | marketbeat.comLabcorp Holdings Inc: Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthSeptember 16, 2024 | finanznachrichten.deLabcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthSeptember 16, 2024 | prnewswire.comFY2024 EPS Estimates for OPKO Health, Inc. (NASDAQ:OPK) Increased by AnalystOPKO Health, Inc. (NASDAQ:OPK - Free Report) - Analysts at Zacks Research upped their FY2024 EPS estimates for shares of OPKO Health in a report released on Wednesday, September 11th. Zacks Research analyst R. Department now expects that the biotechnology company will earn ($0.29) per share for tSeptember 13, 2024 | marketbeat.comY.D. More Investments Ltd Purchases New Position in OPKO Health, Inc. (NASDAQ:OPK)Y.D. More Investments Ltd acquired a new position in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,469,143 shares of the biotechnology cSeptember 12, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Shares Gap Down to $1.59OPKO Health (NASDAQ:OPK) Shares Gap Down to $1.59September 11, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Shares Down 3.3% OPKO Health (NASDAQ:OPK) Shares Down 3.3%September 9, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Shares Gap Down to $1.62OPKO Health (NASDAQ:OPK) Shares Gap Down to $1.62September 5, 2024 | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) Forecasted to Post Q3 2024 Earnings of ($0.11) Per ShareOPKO Health, Inc. (NASDAQ:OPK - Free Report) - Equities research analysts at Zacks Research cut their Q3 2024 earnings estimates for shares of OPKO Health in a note issued to investors on Wednesday, August 28th. Zacks Research analyst R. Department now expects that the biotechnology company willSeptember 2, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Shares Up 4.7%OPKO Health (NASDAQ:OPK) Trading Up 4.7%August 30, 2024 | marketbeat.comStock Traders Buy High Volume of OPKO Health Call Options (NASDAQ:OPK)OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) saw some unusual options trading activity on Thursday. Traders bought 4,992 call options on the company. This is an increase of approximately 124% compared to the typical volume of 2,230 call options.August 29, 2024 | marketbeat.comNot Enough To Keep OPKO Health FlyingAugust 28, 2024 | seekingalpha.com Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address 917 Trades… Zero Losses? (Ad)As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.” Go here to see how you can start accessing these opportunities today OPK Media Mentions By Week OPK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPK News Sentiment▼0.660.49▲Average Medical News Sentiment OPK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPK Articles This Week▼53▲OPK Articles Average Week Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PCRX News Today TARO News Today AVIR News Today HRMY News Today ADCT News Today FOLD News Today GERN News Today LGND News Today MNKD News Today CLDX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPK) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OPKO Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OPKO Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
